Return On Equity of Vivos Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vivos Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Vivos Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -351%, a 4.8% decline year-over-year.
  • Vivos Therapeutics, Inc. annual Return On Equity for 2024 was -198%, a 65% increase from 2023.
  • Vivos Therapeutics, Inc. annual Return On Equity for 2023 was -569%, a 201% decline from 2022.
  • Vivos Therapeutics, Inc. annual Return On Equity for 2022 was -189%, a 153% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Vivos Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -351% -16% -4.8% 01 Jul 2025 30 Sep 2025
Q2 2025 -233% +420% +64% 01 Apr 2025 30 Jun 2025
Q1 2025 -170% +1819% +91% 01 Jan 2025 31 Mar 2025
Q4 2024 -198% +371% +65% 01 Oct 2024 31 Dec 2024
Q3 2024 -335% +107% +24% 01 Jul 2024 30 Sep 2024
Q2 2024 -652% -337% -107% 01 Apr 2024 30 Jun 2024
Q1 2024 -1990% -1768% -798% 01 Jan 2024 31 Mar 2024
Q4 2023 -569% -380% -201% 01 Oct 2023 31 Dec 2023
Q3 2023 -442% -301% -213% 01 Jul 2023 30 Sep 2023
Q2 2023 -316% -209% -194% 01 Apr 2023 30 Jun 2023
Q1 2023 -222% -145% -188% 01 Jan 2023 31 Mar 2023
Q4 2022 -189% -114% -153% 01 Oct 2022 31 Dec 2022
Q3 2022 -141% -65% -85% 01 Jul 2022 30 Sep 2022
Q2 2022 -107% -13% -14% 01 Apr 2022 30 Jun 2022
Q1 2022 -77% +113% +59% 01 Jan 2022 31 Mar 2022
Q4 2021 -75% +353% +83% 01 Oct 2021 31 Dec 2021
Q3 2021 -76% 01 Jul 2021 30 Sep 2021
Q2 2021 -94% 01 Apr 2021 30 Jun 2021
Q1 2021 -190% 01 Jan 2021 31 Mar 2021
Q4 2020 -428% 01 Oct 2020 31 Dec 2020

Vivos Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -198% +371% +65% 01 Jan 2024 31 Dec 2024
2023 -569% -380% -201% 01 Jan 2023 31 Dec 2023
2022 -189% -114% -153% 01 Jan 2022 31 Dec 2022
2021 -75% +353% +83% 01 Jan 2021 31 Dec 2021
2020 -428% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.